Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Whitcup

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
International Journal of Inflammation|October 11, 2013
Inflammation in retinal diseaseScott M Whitcup, Robert B Nussenblatt, Susan L Lightman, et al.
Retina (Philadelphia, Pa.)|October 2, 2008
Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edemaJulia A Haller, Pravin Dugel, David V Weinberg, et al.
Retina (Philadelphia, Pa.)|December 15, 2015
RELATIONSHIP BETWEEN RETINAL THICKNESS AND VISUAL ACUITY IN EYES WITH RETINAL VEIN OCCLUSION TREATED WITH DEXAMETHASONE IMPLANTRonald P Danis, Srinivas Sadda, Jenny Jiao, et al.
Ocular Immunology and Inflammation|June 5, 2003
The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritisDarby J S Thompson, Karyl S Barron, Scott M Whitcup, et al.
Clinical Therapeutics|March 5, 2004
Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitisScott M Whitcup, Ron Bradford, John Lue, et al.
Current Medical Research and Opinion|April 7, 2005
A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitisRichard W Yee, Michael Tepedino, Paula Bernstein, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 29, 2010
A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostE Randy Craven, Ching-Chi Liu, Amy Batoosingh, et al.
Ophthalmic Surgery and Lasers|July 24, 2002
Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphomaGisela Velez, H Culver Boldt, Scott M Whitcup, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 22, 2011
Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trialsDavid Wirta, Amanda M Vandenburgh, Emily Weng, et al.
The British Journal of Ophthalmology|November 20, 2015
Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trialsRonald P Danis, Srinivas Sadda, Xiao-Yan Li, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
International Journal of Inflammation|October 11, 2013
Inflammation in retinal diseaseScott M Whitcup, Robert B Nussenblatt, Susan L Lightman, et al.
Retina (Philadelphia, Pa.)|October 2, 2008
Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edemaJulia A Haller, Pravin Dugel, David V Weinberg, et al.
Retina (Philadelphia, Pa.)|December 15, 2015
RELATIONSHIP BETWEEN RETINAL THICKNESS AND VISUAL ACUITY IN EYES WITH RETINAL VEIN OCCLUSION TREATED WITH DEXAMETHASONE IMPLANTRonald P Danis, Srinivas Sadda, Jenny Jiao, et al.
Ocular Immunology and Inflammation|June 5, 2003
The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritisDarby J S Thompson, Karyl S Barron, Scott M Whitcup, et al.
Clinical Therapeutics|March 5, 2004
Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitisScott M Whitcup, Ron Bradford, John Lue, et al.
Current Medical Research and Opinion|April 7, 2005
A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitisRichard W Yee, Michael Tepedino, Paula Bernstein, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 29, 2010
A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostE Randy Craven, Ching-Chi Liu, Amy Batoosingh, et al.
Ophthalmic Surgery and Lasers|July 24, 2002
Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphomaGisela Velez, H Culver Boldt, Scott M Whitcup, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 22, 2011
Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trialsDavid Wirta, Amanda M Vandenburgh, Emily Weng, et al.
The British Journal of Ophthalmology|November 20, 2015
Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trialsRonald P Danis, Srinivas Sadda, Xiao-Yan Li, et al.
Pageof 7